Status:

RECRUITING

Implantoplasty as Adjunct to Combined Surgical Therapy of Peri-Implantitis

Lead Sponsor:

Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

Conditions:

Peri-Implantitis

Eligibility:

MALE

18-80 years

Phase:

NA

Brief Summary

Implantoplasty entails polishing of the implant surface during the surgical therapy of peri-implantitis. Given the controversy behind implantoplasty as surface decontamination method in the treatment ...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • All patients in age of 18 to 80, non-smokers
  • With no presence of systemic disease or medication known to alter bone metabolism, and partial or complete edentulous patients that have no active periodontal disease.
  • Peri-implantitis defined according to the EFP/AAP consensus meeting
  • Combined defect configuration
  • Exclusion criteria:
  • Pregnancy or lactation
  • History of or current smokers
  • Uncontrolled medical conditions,
  • Cement-retained restoration
  • Lacking keratinized mucosa (≤2mm) on the lingual or buccal implant sites.

Exclusion

    Key Trial Info

    Start Date :

    November 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    November 1 2024

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06131567

    Start Date

    November 1 2021

    End Date

    November 1 2024

    Last Update

    March 21 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centro de Implantologia Cirugia Oral y Maxilofacial

    Badajoz, Spain, 06011